Bendamustine Injection and Vemurafenib: Interaction Details

Brand names
Bendamustine Injection
BelrapzoBendekaTreanda +2 more
Vemurafenib
Zelboraf
Same medicines, other forms
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page

A close look at the Bendamustine Injection and Vemurafenib interaction:

Share

Share this interaction

Bendamustine Injection

Brand names
  • Belrapzo
  • Bendeka
  • Treanda
  • Vivimusta
  • Gobarden

What Happens When You Take Bendamustine Injection With Vemurafenib

What can happen when they are taken together (rated Major)

Increased bendamustine exposure and an increased risk of bendamustine-related adverse effects

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

When a is given together with bendamustine, bendamustine exposure may rise and exposure to its minor active may fall,23 and the likelihood of adverse effects attributable to bendamustine may also be heightened.1 While a patient is receiving bendamustine, therapeutic alternatives that do not inhibit CYP1A2 should be considered.21

The Bendamustine Injection and Vemurafenib Interaction, Explained

Bendamustine is a chemotherapy medicine, and vemurafenib (Zelboraf) is a cancer pill used for certain melanomas. Your body uses a liver enzyme called to break down bendamustine. Vemurafenib can slow that enzyme down, so bendamustine could build up in your blood. That might raise the chance of bendamustine side effects like low blood counts, infections, nausea, tiredness, or skin rash.

This concern is based on how the drugs work, not on reports in real patients. Please don't change anything on your own. Your oncology team can weigh your options and keep a close eye on you.

Mechanism: Vemurafenib is a moderate . Bendamustine is in part by CYP1A2 to minor active (gamma-hydroxybendamustine, N-desmethylbendamustine). may increase parent bendamustine exposure and decrease metabolite exposure.

  • Direction: increased bendamustine exposure and risk of toxicity (, infection, infusion and skin reactions, ).
  • Magnitude/onset: not quantified, onset unspecified.
  • Evidence: theoretical, based on the known metabolic pathway. No clinical interaction data are available.
  • Management: Consider alternative agents that are not CYP1A2 during bendamustine therapy. If is necessary, monitor CBC, signs of infection, and dermatologic and toxicity more closely.

See the 3 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Bendamustine Injection and Vemurafenib Interact

The likely mechanism

of -mediated of bendamustine

In short: Vemurafenib slows CYP1A2, an enzyme that breaks down bendamustine, so bendamustine can build up in the body.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When One Drug Raises Another’s Level”, one chapter of our one-minute explainer. See how it works 

How to Manage the Bendamustine Injection and Vemurafenib Interaction

Labeling advice for bendamustine suggests that care teams consider other treatments that do not block the enzyme while bendamustine is being given. Vemurafenib does block this enzyme.

  • Your oncology team may choose a different medicine, or they may monitor you more closely if both are needed.
  • Keep taking your medicines as prescribed. Do not stop or change anything on your own.
  • Make sure every prescriber knows you take both drugs.
  • Tell your care team right away about fever, chills, unusual bruising or bleeding, a new rash, or feeling much more tired than usual.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Bendamustine Injection or Vemurafenib need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Bendamustine Injection and Vemurafenib: Common Questions

How serious is the Bendamustine Injection and Vemurafenib interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Bendamustine Injection and Vemurafenib interaction managed?

Labeling advice for bendamustine suggests that care teams consider other treatments that do not block the enzyme while bendamustine is being given. Vemurafenib does block this enzyme. Your oncology team may choose a different medicine, or they may monitor you more closely if both are needed. Keep taking your medicines as prescribed. Do not stop or change anything on your own. Make sure ever… Management is individual — always follow your own care team's guidance.

Does taking Bendamustine Injection and Vemurafenib at different times of day help?

No. Taking them at different times of day does not prevent this one. Vemurafenib slows , an enzyme that breaks down bendamustine, so bendamustine can build up in the body. That change lasts while vemurafenib is being taken and can continue for a while after the last dose.

Your pharmacist or prescriber can tell you how they will manage it.

Is there an alternative to taking Bendamustine Injection with Vemurafenib?

Your oncology team may choose a different medicine, or they may monitor you more closely if both are needed.

Only your prescriber can decide whether a change fits you, so talk with them before changing either medicine.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Bendamustine Injection and Vemurafenib Interaction

Ask in your own words about taking Bendamustine Injection and Vemurafenib together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (3)

  1. Product Information: VIVIMUSTA intravenous injection, bendamustine HCl intravenous injection. Slayback Pharma LLC (per FDA), Princeton, NJ, 2022. DailyMed
  2. Product Information: BENDEKA(R) intravenous injection, bendamustine HCl intravenous injection. Teva Pharmaceuticals USA Inc (per manufacturer), North Wales, PA, 2019. DailyMed
  3. Product Information: TREANDA(R) IV injection, bendamustine hcl IV injection. Cephalon,Inc, Frazer, PA, 2008.
Was this write-up helpful?

Other Serious Interactions of Bendamustine Injection and Vemurafenib

Also serious with Bendamustine Injection

Also serious with Vemurafenib

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Vemurafenib

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.